{
    "title": "AstraZeneca says Imfinzi combo shows promise in late-stage lung cancer trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10968249/AstraZeneca-says-Imfinzi-combo-shows-promise-late-stage-lung-cancer-trial.html",
    "date": "2022-06-30",
    "keywords": [
        "cancer",
        "lung",
        "surgery",
        "combination",
        "imfinzi",
        "chemotherapy",
        "trial",
        "form",
        "cell",
        "oncology",
        "area",
        "year",
        "health",
        "june",
        "thursday",
        "drug",
        "promise",
        "latestage",
        "data",
        "tissue",
        "drugmaker",
        "result",
        "boost",
        "companys",
        "focus",
        "therapy",
        "httpsreutrs3nq1chi",
        "astrazeneca",
        "goal",
        "survival",
        "class",
        "bodys",
        "body",
        "treatment",
        "response",
        "strategy",
        "executive",
        "vice",
        "president",
        "rampd",
        "nonsmall",
        "accounting",
        "disease",
        "world",
        "organization",
        "reporting",
        "karimi",
        "pushkala",
        "aripaka",
        "bengaluru",
        "editing",
        "anil",
        "dsilva"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}